FDAnews
www.fdanews.com/articles/113564-merck-anticipates-shortage-of-hepatitis-b-vaccine-recombivax-hb

Merck Anticipates Shortage of Hepatitis B Vaccine Recombivax HB

January 8, 2009
Merck expects an interruption of U.S. supplies this month for Recombivax HB, the adult formulation of its hepatitis B vaccine. The vaccine supply for adults probably will be depleted during the first quarter of this year, but the company does not foresee any effect on the pediatric formulation, according to a Centers for Disease Control and Prevention website on vaccine shortages.
Drug Industry Daily